Close

The 2015 BIO International Convention Closes in Philadelphia - Event Sets New Record for Partnering Meetings

Jun 18 2015
This year’s Convention hosted 29,279 partnering meetings, a new record for the event. Organized by the Biotechnology Industry Organization (BIO), the event drew 15,858 industry leaders from 69 countries and 47 states, as well as the District of Columbia and Puerto Rico.

Scientific American’s Annual Worldview Edition 2015 Launches at BIO 2015

Jun 18 2015

...

Congressional Hearing Highlights Need for Safe and Accurate Food Labeling Act

Jun 18 2015
Consumers deserve uniform, science-based food labeling standards according to expert testimony at a Congressional hearing today on biotech food labeling.

Biotechnology Industry Organization to become Biotechnology Innovation Organization

Jun 17 2015
BIO's new Board Chair, Ron Cohen, CEO of Acorda Therapeutics, announced during Wednesday afternoon's Keynote Luncheon of the 2015 BIO International Convention that the Biotechnology Industry Organization would soon become the Biotechnology Innovation Organization.

Texas State Representative Zerwas Honored as BIO Legislator of the Year

Jun 17 2015
BIO announced today its selection of Texas State Representative John Zerwas (District 28) as a Legislator of the Year for 2015.

Washington State Senator Parlette Honored as BIO State Legislator of the Year

Jun 17 2015
BIO announces today its selection of Washington State Senator Linda Evans Parlette (R-12) as a state Legislator of the Year for 2015.

New Jersey State Assemblywoman Lampitt Honored as BIO State Legislator of the Year

Jun 17 2015
New Jersey State Assemblywoman Pamela Lampitt (6th District) is a BIO Legislator of the Year for 2015

Tennessee State Representative Sexton Honored as BIO State Legislator of the Year

Jun 17 2015
BIO announces its selection of Tennessee State Representative Cameron Sexton (District 25) as a state Legislator of the Year for 2015.

BIO Releases White Paper Encouraging Industry to Include the Patient Voice Early in Drug Discovery

Jun 17 2015
BIO released a white paper - A Lifecycle Approach to Structured Benefit/Risk Assessment Framework - to encourage companies to incorporate and reflect patient preferences throughout the drug development lifecycle. The white paper release coincides with the BIO International Convention, taking place this week in Philadelphia, Penn.

New White Paper from BIO, NORD, and EY Finds Orphan Drug Tax Credit is Crucial to Rare Disease R&D

Jun 17 2015
Important Legislation Helps More Than 30 Million Americans Suffering From Rare Diseases